Ayşe Ağbaş

844 citations
31 papers · 233 indexed · h-index 10
Topics
COVID-19 Clinical Research Studies (6 papers)Renal Diseases and Glomerulopathies (4 papers)SARS-CoV-2 and COVID-19 Research (3 papers)
Journals
SHILAP Revista de lepidopterologíaPLoS ONEFrontiers in Microbiology

In The Last Decade

Ayşe Ağbaş

28 papers receiving 227 citations

Peers

Ayşe Ağbaş
Comparison fields: 5 of 52
  • Nephrology 66
  • Infectious Diseases 55
  • Pathology and Forensic Medicine 43
  • Nutrition and Dietetics 42
  • Surgery 36
Replace Frances Harley with:
Frances Harley Canada
Won-Ho Hahn South Korea
Elen Almeida Romão Brazil
R. Rigby Australia
Hubert Wong Canada
Nilüfer Göknar Türkiye
Nilgün Selçuk Duru Türkiye
Varvara Askiti Greece
H. Kâaroud Tunisia
Giacomo Mori Italy
Ayşe Ağbaş relative to Frances Harley Canada Frances Harley's profile →
Citations per field
00.5×3.9×
Frances Harley · 1×
Citations per year

Countries citing papers authored by Ayşe Ağbaş

Since Specialization
Citations

This map shows the geographic impact of Ayşe Ağbaş's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayşe Ağbaş with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayşe Ağbaş more than expected).

Fields of papers citing papers by Ayşe Ağbaş

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayşe Ağbaş. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayşe Ağbaş. The network helps show where Ayşe Ağbaş may publish in the future.

Co-authorship network of co-authors of Ayşe Ağbaş

This figure shows the co-authorship network connecting the top 25 collaborators of Ayşe Ağbaş. A scholar is included among the top collaborators of Ayşe Ağbaş based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayşe Ağbaş. Ayşe Ağbaş is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 1
4 0
5 3
6 2
7 2
8 2
9 1
10 15
11 43
12 2
13 2
14 6
15 3
16 13
17 10
18 34
19 18
20 11

About Ayşe Ağbaş

Ayşe Ağbaş is a scholar working on Nephrology, Health Informatics and Transplantation, having authored 31 papers that have together received 233 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (6 papers), Renal Diseases and Glomerulopathies (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). The work is most often cited by research in Nephrology (66 citations), Emergency Medical Services (26 citations) and Infectious Diseases (55 citations). Ayşe Ağbaş has collaborated with scholars based in Türkiye, Antigua and Barbuda and United Kingdom. Frequent co-authors include Nur Canpolat, Salim Çalışkan, Lale Sever, Gülşen Akkoç, Mehmet Taşdemir, Nilgün Selçuk Duru, Murat Elevli, Özlem Akgün, Elvan Bayramoğlu and Rukshana Shroff. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Frontiers in Microbiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026